Business

Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call C...

articleCipher Pharmaceuticals Inc.May 9, 20224/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2022-earnings-release-and-conference-call
Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 0pt initial; BORDER-RIGHT:black 0pt initial; BORDER-BOTTOM:black 0pt initial; BORDER-LEFT:black 0pt initial\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n OAKVILLE, ON\n \n \n ,\n \n \n May 9, 2022\n \n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"\n \n the Company\n \n \") today announced that  it will release its Q1 2022 financial results on\n \n Thursday, May 12, 2022\n \n after market close. The Company will also host a conference call on\n \n Friday, May 13, 2022\n \n at\n \n 8:30am ET\n \n to discuss the results and corporate developments.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n \n May 13, 2022\n \n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n \n 8:30 a.m. ET\n \n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n \n (647) 484-0477 or (888) 458-4121\n \n \n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n \n 6137413\n \n \n \n \n \n \n \n \n \n REPLAY DIAL-IN:\n \n \n \n \n \n \n \n (888) 203-1112 (playback 6137413#)\n \n \n \n \n \n \n \n \n \n \n \n Expires May 20, 2022\n \n \n \n \n \n \n \n \n \n WEBCAST:\n \n \n \n \n \n \n \n \n https://produceredition.webcasts.com/starthere.jsp?ei=1548662&tp_key=a2eab0e46f\n \n \n \n \n \n \n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products ...

More updates from Cipher Pharmaceuticals Inc.